Patent · US Active

Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing I

US9925195B2 · kind B2 · utility

1Cited by

3References

9Claims

0Family size

Assignee

LES LABORATOIRES SERVIER · FR

Inventors

Alexandre Le Flohic · Bolbec, FR
Jérôme GUIDOTTI · Yvetot, FR
Philippe Letellier · Bellac, FR

Key dates

Filing date	Jul 11, 2014
Grant date	Mar 27, 2018
Priority date	—
Expiry date	Jul 11, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

3-[3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione methanesulphonate of formula (II):Medicinal products containing the same which are useful in treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.